Optimalizace nové generace myeloidních dendritických buněk pro protinádorovou vakcinaci

Warning

This publication doesn't include Faculty of Arts. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Title in English Optimalization of new generation myeloid dendritic cells for anti-cancer vaccination
Authors

SKÁLOVÁ Kateřina MACKOVÁ Klára MICHÁLEK Jaroslav

Year of publication 2009
Type Conference abstract
MU Faculty or unit

Faculty of Medicine

Citation
Description Dendritic cells (DC) belong to antigen-presenting cells. Their main function is activation of helper and cytotoxic T-cells. DC are able to present tumour antigens and induce immune response of the body against the tumour. DC are sufficient for anticancer-vaccines preparation. In various experimental studies it has been proven, that DC cultured with different methods considerably differ in their properties. In recent years it was insisted on DC immune phenotype (CD80+, CD83+, CD86+, HLA-DR+ a CD14-). Currently, the ability of specific activation of Th1 helper T-cells and cytotoxic T-cells in mixed leukocyte culture seems to be critical. This ability is connected with production of interleukin 12 (IL-12) ,which supports anti-tumour immune response. On the contrary, production of IL-10, which suppresses T-cell activation, is unwanted. In this study we compared five different methods of DC production, sufficient for use in clinical studies.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.